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Abstract 
Background: Hepatitis C virus (HCV) has emerged as a 
leading cause of chronic hepatitis, liver cirrhosis and 
hepatocellular carcinoma worldwide. Hepatitis C is 
rapidly emerging as a major health problem in developing 
countries including Pakistan. Serum Alanine 
Aminotransferase (ALT) is the most frequently utilized 
screening test in routine evaluation of liver damage. This 
study was conducted to determine the seroprevalence of 
hepatitis C virus infection and its association with serum 
alanine aminotransferase. 
Objective: Determination of the seroprevalence of 
hepatitis C virus infection and its association with serum 
alanine aminotransferase in patients at social security 
hospital, Islamabad. 
Material and Methods: A cross sectional study was 
conducted at clinical laboratory of social security hospital 
Islamabad, from May 2009 to October 2009. All samples 
referred to social security hospital for hepatitis profile 
were included in the study. All patients were screened 
serologically for hepatitis C virus antibodies and serum 
alanine aminotransferase was determined in selected HCV 
positive patients only. 
Results: Out of 1006 blood samples 146 were positive for 
anti-HCV antibodies with an overall positivity of 14.5%. 
Out of these 55% cases were males and 45% were females. 
Seroprevalence of HCV was found to be 8% in the age 
group of <20 years, and almost equal i.e. 46% and 49% in 
20-40 years and >40 years age groups respectively. Serum 
ALT was determined in total 83 patients only: they showed 
 levels less than 30U/L in 25% patients, 30-45U/L in 15% 
patients, 46-60U/L in 19% patients, 61-100U/L in 29% 
patients and more than 100U/L in 12% patients. 
Conclusion: The present study revealed that 
prevalence of HCV was 14.5% and ALT levels were found 
to be more than 45U/L in 75% of the anti HCV positive 
cases, showing the significance of this biochemical marker 
as diagnostic tool in such patients. 
 
 
Introduction 
Hepatitis C is rapidly emerging as a major health problem in 
developing countries including Pakistan.1-5 It is estimated 
that 3–4 million people are infected with HCV each year. 
Some 130–170 million people are chronically infected with 
HCV and at risk of developing liver cirrhosis and/or liver 
cancer. More than 350,000 people die from HCV-related 
liver diseases each year. Countries with high rates of chronic 
infection are Egypt (22%), Pakistan (4.8%) and China 
(3.2%).6 In Pakistan 10 million people are presumed to be 
infected with HCV. 7, 8 Seroprevalence studies of anti-HCV 
antibodies in the general population of Pakistan have been 
recorded as 5.31% to 7.5%.9-11 Serum Alanine 
Aminotransferase (ALT) is the most frequently utilized 
screening test in routine evaluation of liver damage.12, 13 
ALT is most concentrated in liver and released into the 
bloodstream as the result of liver injury. It, therefore, serves 
as a fairly specific indicator of liver status.14,15 However, 
there are conflicting reports on the relationship between the 
biochemical markers of inflammation and ALT.16 Hence this 
study was designed with an aim to determine the 
seroprevalence of hepatitis C virus infection and its 
association with serum alanine aminotransferase in our 
population. 
 
Material and Methods 
A cross-sectional study was conducted at clinical laboratory 
of Social security Hospital Islamabad, for a period of six 
months from May 2009 to October 2009. All blood samples 
referred for HCV profile were checked for anti HCV. Serum 
alanine aminotransferase was tested in those patients who 
were found positive for anti HCV.  Samples were subjected 
to serological analysis for anti-HCV antibodies using rapid 
immune chromatography kits (ICT, Australia and Abbott, 
USA) and positive samples were confirmed by ELISA 
(IMX, Abbott, USA). ALT was performed by standard 
biochemical method on Microlab. Results were entered on 
SPSS version 14 for final analysis. 
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Results 
Total number of cases referred for HCV profile was 1006. 
Out of these 146 cases were positive for anti-HCV 
antibodies; hence overall positivity was 14.5%. Among 
these 55.5% were males and 44.5 % were females with male 
to female ratio of 1.2:1. Prevalence of Hepatitis C was found 
to be 8% in the age group of <20 years, and almost equal i.e. 
46% and 49% in 20-40 years and more than 40 years groups 
respectively (table.1).  
Table 1: HCV Positivity in Relationship with Age (n=146) 
Age in years No. (%) 
<20 
20-40 
>40 
8 (5.48) 
67 (45.89) 
71 (48.63) 
 
Table 2: ALT levels in anti-HCV positive patients  
Serum ALT level 
 (U/l) 
No. (%) Mean ±S.D 
 
<30 
30-45 
46-60 
61-100 
>100 
21(25.30) 
12(14.46) 
16(19.28) 
24(28.92) 
10(12.05) 
21.81± 4.26 
35.17± 4.60 
53.38± 5.71 
78.58± 9.72 
250.1± 186 
 
Serum ALT was checked in total 83 patient’s blood 
samples. Our study showed levels less than 30U/L in 21 
patients, 30-45U/L in 12 patients, 46-60U/L in 16 patients, 
61-100U/L in 24 patients and more than 100U/L in 10 
patients (table.2). Reference ranges for ALT established in 
our lab are 3-33U/L. 
 
Discussion 
Prevalence of HCV may be different in different regions and 
various groups of the same community. 17 In our hospital 
based study seroprevalence of HCV was 14.5%. Hospital-
based studies revealed seroprevalence rates of anti-HCV as 
5.31% in Islamabad,18 2.45%-20.89% in various parts of the 
Punjab province. 4,19-20  Seroprevalence of HCV was 4-6% 
in Karachi, 5 5%-9% in North West Frontier Province (N-
W.F.P) 21,22 and 25.7% in Northern Areas. 23 Our study is 
partially in agreement with another study, in which 
prevalence of active HCV infection in district Mansehra 
Pakistan was 7%1. Slightly higher prevalence of HCV was 
recorded in the earth quake affected areas of Pakistan in 
2005. 3 High prevalence of HCV infection in male 
population has earlier been recorded by other studies from 
Pakistan and around the globe. In our hospital based study 
males were more commonly affected than females, the 
results comparable with another study conducted by Ahmed 
et al at Jinnah Postgraduate Medical Centre, Karachi as 55% 
Hepatitis C cases were males and 45 % females. 24   
In relation to age group we also observed a high prevalence 
of HCV among adults i.e. more than 40 years (48.63%) 
followed by individuals between 20-40 years (45.89 %). On 
the other hand, the prevalence in less than 20 year age group 
was significantly low (5.48%). This shows that the 
prevalence of HCV increased with increasing age. This was 
in agreement with another study that showed high 
prevalence of HCV among middle-aged (40-50 years) group 
and lowest between 21-30 years. 1 
In developing countries, ALT testing continues to be 
employed as a diagnostic marker for HCV infection based 
on the assumption that recent HCV infection can be detected 
earlier by ALT than by anti-HCV. The serological screening 
test may miss a hepatitis C virus infection before hepatitis C 
virus antibodies are detected. 12, 25 In 63% of patients in our 
study value of ALT were found to be between 30-100U/L. 
This study is in agreement with a study conducted in 
Postgraduate Institute of Peshawar which showed that 
majority of HCV-positive patients in different stages of 
infection had ALT levels between 41-80U/L; the study also 
showed that there is a close correlation between elevation of 
ALT and HCV infection.26 This pattern is strongly 
supported by the works of Wang, Rodger, and Shang who 
found a strong correlation between the prevalence of an 
elevated serum ALT level and HCV positivity.26-29  This 
finding suggests that we can use the prevalence of an 
elevated serum ALT level for identifying the communities 
with high prevalence of HCV infection. Considering that the 
per unit cost of the anti-HCV test is 5 to 25 times that of the 
serum ALT level  test ,  the  overall  cost  for  conducting  
such  regional or national survey of HVC infection can be 
significantly reduced using the serum ALT levels. 
Moreover, performing serum ALT levels in the field is much 
more feasible than performing the anti-HCV test. Our data 
has important implications in terms of cost, and feasibility 
for monitoring a communicable disease in communities, 
particularly in hyper endemic areas. In summary, the 
prevalence of an elevated serum ALT level is a valuable 
index for identifying the communities at the high risk of 
HCV infection. Population with elevated serum ALT levels 
may then be checked for HCV infection. 26, 27  
 
Conclusion 
The present study revealed that prevalence of HCV was 
14.5% and that there was a close correlation of ALT with 
anti HCV positivity. It is recommended that if screening for 
HCV is not possible then ALT should be checked and a mild 
elevation in ALT should be taken as a base for HCV 
screening. 
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